SCHEMBL15964265

SCHEMBL15964265

CCn1c2ccccc2c2c3c4ccccc4n(C)c3ccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
GPR3 P46089 1/20 0.52
KDM4E B2RXH2 9/20 0.51
MAPT P10636 8/20 0.51
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
HTT P42858 4/20 0.51
TDP1 Q9NUW8 3/20 0.51
MAPK1 P28482 3/20 0.51
HSD17B10 Q99714 3/20 0.51
HPGD P15428 1/20 0.51
HBB P68871 1/20 0.51
NPC1 O15118 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
GAA P10253 1/20 0.49
RAB9A P51151 1/20 0.49
ATM Q13315 1/20 0.49
PTGER4 P35408 1/20 0.47
NQO2 P16083 1/20 0.47
LMNA P02545 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16978834 0.91 ALDH1A1 (0.64) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL19769367 0.88 ALDH1A1 (0.44) ALDH1A1GPR3KDM4EMAPTMEN1
SCHEMBL25545167 0.88 ALDH1A1 (0.49) ALDH1A1GPR3KDM4EMAPTMEN1
SCHEMBL14313953 0.84 GPR3 (0.71) ALDH1A1GPR3KDM4EMAPTMEN1
SCHEMBL19769371 0.84 TP53 (0.56) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL19769366 0.84 CYP1A2 (0.63) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL15964263 0.83 GPR3 (0.50) ALDH1A1GPR3KDM4EMAPTMEN1
SCHEMBL15964274 0.83 KDM4E (0.50) ALDH1A1GPR3KDM4EMAPTMEN1
SCHEMBL19769393 0.83 MAPT (0.49) ALDH1A1GPR3KDM4EMAPTMEN1
SCHEMBL25806689 0.80 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142222-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2023-05-11 US disclosed
US-20230128732-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL AND ORGANIC ELECTROLUMINESCENCE ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2023-04-27 US disclosed
US-9716238-B2 Boron compound for organic electroluminescent elements, and organic electroluminescent element NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) 2017-07-25 US disclosed
US-20160293853-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2016-10-06 US disclosed
US-9397307-B2 Organic electroluminescence device and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2016-07-19 US disclosed
US-20160020397-A1 BORON COMPOUND FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) 2016-01-21 US disclosed
US-20140231769-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160020397-A1 BORON COMPOUND FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT EBPL, CDYL, L3MBTL3 ALDH1A1 2497/4885GPR3 4164/4885KDM4E 567/4885
US-20160293853-A1 Organic Electroluminescent Materials and Devices OCIAD1, OCIAD2, JUND ALDH1A1 400/4885GPR3 3529/4885KDM4E 666/4885
US-20230142222-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT LEF1, CTNNA1, CCNT1 ALDH1A1 161/4885GPR3 1051/4885KDM4E 2601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.